Bioray Biotech CoROCO:7561 -3.45%82 Gross Margin % is 45.29% as of Dec. 2025, which is 1% above its 10-year median of 44.67. GuruFocus rates ROCO:7561 with a GF Score™ of 82/100 and a GF Value™ of NT$29.49 (Significantly Undervalued). Among 938 Drug Manufacturers companies, Bioray Biotech Co ranks worse than 51.92% on this metric.
The historical rank and industry rank for Bioray Biotech Co's Gross Margin % or its related term are showing as below:
ROCO:7561'
s Gross Margin % Range Over the Past 10 Years
Min: 39.18 Med: 44.67 Max: 54.7
Current: 47.56
During the past 9 years, the highestGross Margin % of Bioray Biotech Co was 54.70%. The lowest was 39.18%. And the median was 44.67%.
ROCO:7561's Gross Margin % is ranked worse than 51.92% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs ROCO:7561: 47.56
Bioray Biotech Co had a gross margin of 45.29% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Bioray Biotech Co was -0.10% per year.
Bioray Biotech Co (ROCO:7561) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Bioray Biotech Co had a gross margin of 45.29% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Bioray Biotech Co Gross Margin % Related Terms
Bioray Biotech Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for Bioray Biotech Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bioray Biotech Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioray Biotech Co Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bioray Biotech Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Bioray Biotech Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Bioray Biotech Co (ROCO:7561) has a Gross Margin % of 45.29% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Bioray Biotech Co and its competitors. This is near median its historical median of 44.67. Over the past decade, Bioray Biotech Co's Gross Margin % has ranged from 39.18 to 54.70. According to the industry distribution chart, Bioray Biotech Co ranks #487 out of 938 companies in the Drug Manufacturers industry, placing it in the top 51.9%.
Is Bioray Biotech Co's Gross Margin % too high?
Bioray Biotech Co's current Gross Margin % of 45.29% is near median its 10-year median of 44.67. Over the past 10 years, this metric has ranged from a low of 39.18 to a high of 54.70. The Drug Manufacturers industry median Gross Margin % is 48.54. Bioray Biotech Co's value of 45.29% is 6.7% below this industry median. Based on the distribution chart, Bioray Biotech Co ranks #487 out of 938 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Bioray Biotech Co has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioray Biotech Co's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Bioray Biotech Co ranks #487 out of 938 companies for Gross Margin %. This places Bioray Biotech Co in the lower half of its industry. The industry median Gross Margin % is 48.54. Bioray Biotech Co's value of 45.29% is 6.7% below this benchmark. Historically, Bioray Biotech Co's own Gross Margin % has ranged from 39.18 to 54.70 over the past decade. While the company's 10-year median is 44.67 vs. the industry median of 48.54, Bioray Biotech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioray Biotech Co's current Gross Margin % of 45.29% is 6.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Bioray Biotech Co and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioray Biotech Co's current Gross Margin % is 45.29%, which is near median its own 10-year median of 44.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioray Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Bioray Biotech Co (ROCO:7561) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$29.49, compared to a current price of NT$18.20 — trading 38.3% below its estimated fair value. The current Gross Margin % is 45.29%, which is near median its 10-year median of 44.67 and 6.7% below the Drug Manufacturers industry median of 48.54. Bioray Biotech Co's overall GF Score™ is 82/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Bioray Biotech Co (ROCO:7561), the current Gross Margin % is 45.29% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioray Biotech Co (ROCO:7561) Overvalued in 2026?
Based on GuruFocus' analysis, Bioray Biotech Co stock appears to be undervalued.
The current stock price of NT$18.20 is trading 38.3% below its estimated GF Value™ of NT$29.49.
GuruFocus considers Bioray Biotech Co to be Significantly Undervalued.
Key valuation signals for ROCO:7561:
Gross Margin %: 45.29% (near median its 10-year median of 44.67)
GF Value™: NT$29.49 vs. price of NT$18.20 (38.3% below fair value)
Industry Position: 6.7% below the Drug Manufacturers median (#487 of 938)
No single metric tells the full story. See the ROCO:7561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations.
82GF Score
Get the complete analysis for ROCO:7561
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7561 has been successfully added to your 
